Extracellular vesicle therapy in neurological disorders.

Area of Science:

• Cell Biology
• Biotechnology
• Nanomedicine

Background:

• Extracellular vesicles (EVs) mediate intercellular communication by transferring proteins, lipids, and nucleic acids.
• EVs are implicated in physiological processes like immune modulation and tissue regeneration, as well as pathological conditions such as inflammation and neurodegeneration.
• The heterogeneity of EV populations and their cargo presents both opportunities and challenges for therapeutic applications.

Purpose of the Study:

• To review recent advances in understanding EV heterogeneity.
• To highlight the significance of EV subpopulations in disease pathologies.
• To emphasize the potential of tailored EV therapies for clinical applications, particularly in neurological disorders.

Main Methods:

• Literature review of recent studies on extracellular vesicles.
• Analysis of EV heterogeneity, cargo, and roles in physiological and pathological processes.
• Evaluation of current challenges and future directions in EV therapy development.

Main Results:

• EVs are crucial mediators of cell-to-cell communication with diverse roles.
• EV heterogeneity is significant, with various subpopulations under investigation.
• EV therapy offers advantages over cell therapy but faces challenges in production and characterization.

Conclusions:

• A deeper understanding of EV heterogeneity and function is essential for advancing EV-based therapies.
• Tailored EV therapies hold promise for treating neurological disorders.
• Overcoming challenges in EV production and characterization is critical for clinical translation.